Page 80 - Screening for Cervical Cancer: Systematic Evidence Review
P. 80

References



                 41.   Cecchini S, Ciatto S, Zappa M, Biggeri A. Trends in the prevalence of cervical
                              intraepithelial neoplasia grade 3 in the district of Florence, Italy. Tumori.
                              1995;81:330-333.


                 42.   Mitchell HS, Giles GG. Cancer diagnosis after a report of negative cervical cytology [see
                              comments]. Med J Aust. 1996;164:270-273.


                 43.   Sigurdsson K. Trends in cervical intra-epithelial neoplasia in Iceland through 1995:
                              evaluation of targeted age groups and screening intervals. Acta Obstet Gynecol
                              Scand. 1999;78:486-492.

                 44.   Sawaya GF, Grady D, Kerlikowske K, et al. The positive predictive value of cervical
                              smears in previously-screened postmenopausal women:  the Heart and
                              Estrogen/progestin Replacement Study (HERS). Ann Intern Med. 2000;133:942-
                              950.


                 45.   Miller AB, Visentin T, Howe GR. The effect of hysterectomies and screening on
                              mortality from cancer of the uterus in Canada.  Int J Cancer. 1981;27:651-657.

                 46.   Eaker ED, Vierkant RA, Konitzer KA, Remington PL. Cervical cancer screening among
                              women with and without hysterectomies. Obstet Gynecol. 1998;91:551-555.


                 47.   Fox J, Remington P, Layde P, Klein G. The effect of hysterectomy on the risk of an
                              abnormal screening Papanicolaou test result. Am J Obstet Gynecol.
                              1999;180:1104-1109.

                 48.   Pearce K, Haefner H, Sarwar S, Nolan T. Cytopathological findings on vaginal
                              Papanicolaou smears after hysterectomy for benign gynelogical disease.  N Engl J
                              Med. 1996;335:1559-1562.

                 49.   Weintraub J, Morabia A. Efficacy of a liquid-based thin layer method for cervical cancer
                              screening in a population with a low incidence of cervical cancer. Diagn
                              Cytopathology. 2000;22:52-59.


                 50.   Nanda K, McCrory DC, Myers ER, et al. Accuracy of the Papanicolaou test in screening
                              for and follow-up of cervical cytologic abnormalities: a systematic review. Ann
                              Intern Med. 2000;132:810-819.

                 51.   Hutchinson ML, Zahniser DJ, Sherman ME, et al. Utility of liquid-based cytology for
                              cervical carcinoma screening: results of a population-based study conducted in a
                              region of Costa Rica with a high incidence of cervical carcinoma. Cancer.
                              1999;87:48-55.

                 52.   Roberts JM, Gurley AM, Thurloe JK, Bowditch R, Laverty CRA. Evaluation of the
                              ThinPrep Pap test as an adjunct to the conventional Pap smear. Med J Aust.
                              1997;167:466-469.

                 53.   Bolick DR, Hellman DJ. Laboratory implementation and efficacy assessment of the




                                                             86
   75   76   77   78   79   80   81   82   83   84   85